Serum proteomics for BRCA1-associated breast cancer

Annals of Surgical Oncology

Volumn 11, Issue 10, 2004, Pages 883-884

  Meric Bernstam, Funda ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN;

BLOOD ANALYSIS; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; EDITORIAL; GENE EXPRESSION PROFILING; GENE MUTATION; HUMAN; PROTEIN BLOOD LEVEL; PROTEOMICS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; BREAST TUMOR; FEMALE; FORECASTING; GENETIC PREDISPOSITION; GENETICS; MASS SPECTROMETRY; METHODOLOGY; MUTATION; NOTE; RISK ASSESSMENT; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; FEMALE; FORECASTING; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; MASS SPECTROMETRY; PROTEOMICS; RISK ASSESSMENT;

EID: 16544387138     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2004.08.909     Document Type: Editorial

References (10)

1. Meijers-Heijboer H, van Geel B, van Putten WL, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2001;345:159-64.
2. Rebbeck TR, Friebel T, Lynch HT, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 2004;22:1055-62.
3. Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002;359:572-7.
4. Zhu W, Wang X, Ma Y, et al. Detection of cancer-specific markers amid massive mass spectral data. Proc Natl Acad Sci U S A 2003;100:14666-71.
5. Adam BL, Qu Y, Davis JW, et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 2002;62:3609-14.
6. Vlahou A, Laronga C, Wilson L, et al. A novel approach toward development of a rapid blood test for breast cancer. Clin Breast Cancer 2003;4:203-9.
7. Garber K. Debate rages over proteomic patterns. J Natl Cancer Inst 2004;96:816-8.
8. Diamandis EP. Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems. J Natl Cancer Inst 2004;96:353-6.
9. Becker S, Cazares LH, Watson P, et al. SELDI-TOF (surfaced-enhanced laser desorption/ionization-time of flight) differentiation of serum protein profiles of BRCA-1 and sporadic breast cancer. Ann Surg Oncol 2004;11:907-14.
10. Hedenfalk I, Duggan D, Chen Y, et al. Gene-expression profiles in hereditary breast cancer. N Engl J Med 2001;344:539-48.